Latest Earnings Results: Q3 '26
Estimated EPS
$3.55
Reported EPS
$3.52
Surprise
-0.79%
Estimated Rev
$6.62B
Reported Rev
$6.52B
Surprise
-1.47%
• Reported GAAP EPS of $3.52 up 10.34% YoY • Reported revenue of $6.52B up 7.64% YoY • Stryker is updating full year 2026 guidance to organic net sales growth of 6.5% to 7.0% and adjusted diluted EPS of $14.80 to $14.90; sales guidance includes modestly positive pricing impact.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $5.03 | -- | -- | N/A |
Q3 '26 | $3.55 | $3.52 | -0.79% | MISSED |
Q2 '26 | $3.49 | $3.69 | 5.78% | BEAT |
Q1 '26 | $2.98 | $2.60 | -12.77% | MISSED |
Q4 '25 | $4.40 | $4.47 | 1.68% | BEAT |